Evidence map›Paper›PMID 29844158›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.

Julia A Callender, Yimin Yang, Gema Lordén, Natalie L Stephenson, Alexander C Jones, John Brognard, Alexandra C Newton

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Alzheimer's Pathology Enhances Excitatory Synaptic Input and Integration in VTA Dopamine Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Julia A CallenderDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093.
Yimin YangDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093.
Gema LordénDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093.
Natalie L StephensonCancer Research UK Manchester Institute, The University of Manchester, Manchester 4BX M20, United Kingdom.
Alexander C JonesBiomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92093.
John BrognardCancer Research UK Manchester Institute, The University of Manchester, Manchester 4BX M20, United Kingdom.
Alexandra C NewtonDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093; anewton@ucsd.edu.ORCID 0000-0002-2906-3705
University of California San Diego · USUniversity of Manchester · GB

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Molecular Mechanisms of Cell SignalingR35GM122523 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALEXANDRA C. NEWTON · 2017 to 2026
$6.7M
Structure, Function and Regulation of Protein Kinase CR37GM043154 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NEWTON, ALEXANDRA C. · 2003 to 2012
$4.0M
STRUCTURE/FUNCTION AND REGULATION OF PROTEIN KINASE CR01GM043154 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NEWTON, ALEXANDRA C. · 1990 to 2016
$2.5M
Cancer Research UKNIGMS NIH HHS R01 GM043154NIGMS NIH HHS R35 GM122523NIGMS NIH HHS R37 GM043154NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

Conventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca

Indexed as

Alzheimer DiseaseAnimalsBrainCalciumCatalysisCatalytic DomainCell LineChlorocebus aethiopsCOS CellsCRISPR-Cas SystemsDown-RegulationEnzyme ActivationGain of Function MutationHumansMiceMice, Inbred C57BLCalciumProtein Kinase C-alphaAlzheimer’s diseaseenzyme mutationPKCprotein kinase Csignal transduction

Identifiers

PMID29844158
PMCPMC6004447
OpenAlexW2805651721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.